Overview

Clinical Trial Evaluating the Safety and Efficacy of Moxidectin 2 mg Ivermectin-controlled in Loa Loa Microfilaremic Patients

Status:
Withdrawn
Trial end date:
2021-06-30
Target enrollment:
Participant gender:
Summary
This study aims at evaluating the safety and efficacy of Moxidectin 2 mg in patients with low intensities of microfilariae of Loa loa.
Phase:
Phase 2
Details
Lead Sponsor:
Institut National de la Santé Et de la Recherche Médicale, France
Treatments:
Ivermectin
Milbemycin
Moxidectin